Table 1.
Baseline demographic and clinical characteristics of study population.
| Patients’ characteristics (number of eyes = 41) | |
|---|---|
| Age, (years), mean ± SD | 57 ± 16 |
| Gender, n (male:female) | 13:27 |
| Eye Laterality, n (right:left) | 19:22 |
| CNV duration (days), mean ± SD | 19.6 ± 6.8 |
| Axial length (mm), mean ± SD | 28.78 ± 1.31 |
| Central foveal thickness (μ), mean ± SD | 272 ± 42 |
| Number of injections, mean ± SD | 3.15 ± 1.46 |
| Baseline BCVA, (logMAR), mean ± SD | 0.48 ± 0.34 |
| FA pattern, n (profuse:minimal) | 23:18 |
| CNV maturation pattern, n (immature:mature) | 20:21 |
| Subretinal haemorrhages, n (presence:absence) | 5:36 |
SD standard deviation, mm millimeter, BCVA best-corrected visual acuity, μ micron, CNV Choroidal neovascularization, logMAR logarithm of the minimal angle of resolution.